Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

The treatment landscape for clear cell renal cell carcinoma (ccRCC) could be due for a shake-up following dual breakthroughs ...

Researchers at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center uncovered new evidence that extra copies of a ...

The U.S. Food and Drug Administration (FDA) has granted traditional approval to Braftovi (encorafenib) for adult patients ...

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast ...

Research has uncovered a surprising biological twist: molecules that help support healthy aging can also contribute to cancer growth.

The statistics are sobering and undeniable — African American men develop prostate cancer at twice the rate of white men and are more likely to die from the disease. This reality makes understanding ...

A new study from researchers at the Hebrew University of Jerusalem provides fresh insight into how pancreatic cancer may ...

A doctor highlights subtle ovarian cancer symptoms people often miss and explains why early checks could make a life-saving ...

University Hospital Southampton is leading a study where researchers will see if a diagnostic tampon can help spot the early ...